Discrepancies between the results of M.tuberculosis susceptibility testing by phenotypic and genotypic methods
DOI:
https://doi.org/10.52692/1857-0011.2024.2-79.05Keywords:
M.tuberculosis, drug resistance, methods of sensitivity testingAbstract
The increase in the number of cases of drug-resistant TB and the therapeutic failures in the treatment, imposes the need to optimize the sensitivity tests of M.tuberculosis . There is still no unanimously accepted and reliable method for the laboratory diagnosis of TB and most often the application of several methods is required. Knowledge and synergistic analysis of mutations in the M. tuberculosis genome, evaluation of the results of phenotypic tests with different levels of resistance, as well as information about clinical outcomes will substantially improve the treatment of patients with drug-resistant TB. Evaluation of different types of genotypic resistance, with the description of mutations that confer low or high resistance, is consistent with the level of phenotypic resistance, and also makes it possible to adjust treatment regimens, which in turn positively influence the duration and results of treatment.
References
World Health Organization. Global tuberculosis report 2019. Geneva: WHO/CDS/TB/2019 http://www.who.int/tb/publications/global_report/en/
Sven Hoffner. Multidrug-resistant tuberculosis: The problem and some priorities in controlling it. Int. J.of Mycobacteriology 5 (2016) S59. http://dx.doi.org/10.1016/j.ijmyco.2016.10.031
V. Crudu, Matthias Merker, Christoph Lange, Ecaterina Noroc, Elena Romancenco, D. Chesov, G. Günther, A.Buga, Sofia Alexandru, S.Niemann. Transmission of mycobacterium tuberculosis Ural 16315 lineage causing multidrugresistant tuberculosis among hospitalized patients. Eur Respir J. 2015.Vol. 46 Issue suppl 59. DOI: 10.1183/ 13993003.congress2015.
Cohen T et al. Challenges in estimating the total burden of drug-resistant tuberculosis. American Journal of Respiratory Critical Care and Medicine, 2008, 177(12):1302–1306.
Chitwood MH, Colijn C, Yang C, Crudu V Ciobanu, N Codreanu, A, J Kim, Isabel Rancu, Kyu Rhee, Ted Cohen & Benjamin Sobkowiak . The recent rapid expansion of multidrug resistant Ural lineage Mycobacterium tuberculosis in Moldova. Nature Communications (2024) 15:2962. https://doi.org/10.1038/s41467-024-47282-9
Benjamin Sobkowiak, Patrick Cudahy, Melanie Chitwood, Caroline Colijn, Katharine Walter, Valeriu Crudu, Ted Cohen. A new method for detecting mixed Mycobacterium tuberculosis infection and reconstructing constituent strains provides insights into transmission. bioRxiv doi: https://doi.org/10.1101/2024.04.26.591283
Yu Lan, Valeriu Crudu, Nelly Ciobanu, Alexandru Codreanu, Melanie Chitwood, Benjamin Sobkowiak, and Ted Cohen. Identifying local foci of tuberculosis transmission in Moldova using a spatial multinomial logistic regression model. eBioMedicine 2024;102: 105085 www.thelancet.com Vol 102 April, 2024. https://doi.org/10.1016/j.ebiom.2024.105085
Thirumurugan Ravibalan, Kathirvel Maruthai, Antony
V. Samrot, and Muthuraj Muthaiah. Characterization of katG and rpoB gene mutations in Multi Drug Resistant Mycobacterium tuberculosis clinical isolates. Int.J.Curr.Microbiol.App.Sci (2014) 3(9) 1072-1080 http://www.ijcmas.com
Dhruv Gandhi, Aditi Gupta, Zahabiya Nalwalla, Ira Shah. Discordance between Xpert MTB/ RIF assay and Line Probe Assay- how to interpret? Pediatric Oncall · July 2024 DOI: 10.7199/ped.oncall.2024.39
Anda Vīksna, Darja Sadovska, Iveta Berge, Ineta Bogdanova, Annija Vaivode, Lauma Freimane, Inga Norvaiša, Iveta Ozere and Renāte Ranka. Genotypic and phenotypic comparison of drug resistance profles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia. BMC Infectious Diseases (2023) 23:638 https://doi.org/10.1186/s12879-023-08629-7
Downloads
Published
License
Copyright (c) 2025 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
